Coming Soon

Blue Earth Diagnostics Limited

Registration Number 08773116

Company Overview

Company Name
Blue Earth Diagnostics Limited
Registration Number
08773116
Founded
13 November 2013
Age
10 years
Industry Region
South East England
Registered Postcode
OX4 4GA

Online Profile

false

Special Flags

Public Funding Received

Public Funding for Blue Earth Diagnostics Limited

2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D
2015-04-01
18F FACBC an innovative imaging agent for the diagnosis of prostate cancer: a Phase III evaluation in recurrent prostate cancer
Collaborative R&D

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.